CHRISTOPHER RICHARD 4
4 · Lexaria Bioscience Corp. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
CHRISTOPHER RICHARD
DirectorChief Executive Officer
Transactions
- Purchase
common shares
2025-07-29$0.91/sh+15,000$13,641→ 65,000 total
Holdings
- 200,000
Stock Options
Exercise: $3.92From: 2025-02-28Exp: 2029-08-31→ Common Shares (200,000 underlying) - 50,000
common shares
- 350,000
Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (150,000 underlying)
Footnotes (1)
- [F1]50,000 options were exercisable on Feb. 28, 2025, an additional 6,818 options are exercisable every month thereafter until November 30, 2026 whereby the balance of 6,822 options will be exercisable December 31, 2026